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INTRODUCTION 
Tumor cells have a very distinctive metabolism. Metastasis and 
unlimited growth are distinguishing characteristics of tumor cells not 
seen in normal cells, and these characteristics result in widespread fatal 
malignancies in humans. Several previous studies have considered the 
metabolic changes that take place in the host after tumor implantation. 
Metabolic abnormalities arising from malnutrition and malignancy are 
seen in animals and in patients with cancer cachexia, and various cancers 
affect lipid metabolism.1-7) It was found that rats subcutaneously 
implanted with the ascites hepatoma cell line AH109A show 
hyperlipidemia with a notable decrease in the high-density lipoprotein 
(HDL) fraction and an enormous increase in the very-low-density 
lipoprotein (VLDL) and low-density lipoprotein (LDL) fractions5-7) 
during the growth of the solid tumor.5) AH109A is a hepatoma that 
originates from the liver. The liver carries out major lipid metabolism, 
including cholesterol, fatty acid, and triglyceride biosyntheses, as well as 
VLDL production. It is thus suspected that hepatoma cells affect lipid 
metabolism in the host body and that the cancer state affects lipid 
metabolism. 
RCN-9, a transplantable rat colon adenocarcinoma, was induced in 
the colon of a male Fisher F344 rat by the subcutaneous administration 
of 1, 2-dimethylhydrazine. RCN-9 metastasizes spontaneously, and 
when RCN-9 cells were injected subcutaneously or into the cecal 
subserosa of syngeneic rats, carcinomas with progressive growth were 
obtained and the development of lung and liver metastases, respectively, 
ensued.8) 
In the present study, to investigate the effects of RCN-9 implantation 
on lipid metabolism, I examined the changes in lipid levels in the serum 
and liver of RCN-9-implanted rats. RCN-9 is a colon cancer that 
originates from the colon; the effects of the implanted RCN-9 tumor cells 
on lipid metabolism may be small compared to those of a hepatoma,5-7) 
which originates from the liver and is active in various types of lipid 
metabolism. In addition, since decreases in food intake and body weight 
are seen in the tumor-bearing state as a result of a cancer-induced 
cachexia as mentioned above, I conducted a pair-feeding study to 
investigate the effects of food restriction on tumor bearing in RCN-9-
implanted rats. 
 
MATERIALS AND METHODS 
Animals and diets. This animal experiment was conducted with the 
approval of the Iwate Prefectural University Research Ethics Committee. 
Male F344 rats (3-wk-old, Charles River Laboratories Japan, Inc., 
Kanagawa, Japan) were individually housed in stainless steel cages with 
wire bottoms in an air-conditioned room at the temperature of 22 ± 2 ℃, 
with relative humidity of 55 ± 5 %, and an 8:00 a.m. to 8:00 p.m. light 
cycle. They were kept on a stock pellet diet (MF; Oriental Yeast Co., 
Tokyo, Japan), followed by a basal diet containing 20 % casein.9) The 
composition of the basal diet was as follows: 20 % casein (Oriental Yeast 
Co.), 13.2 % α-cornstarch (Oriental Yeast Co.), 39.75 % cornstarch 
(Oriental Yeast Co.), 10 % sucrose (Nissin Sugar Manufacturing Co., 
Tokyo, Japan), 5 % cellulose powder (Oriental Yeast Co.), 7 % soybean 
oil (Oriental Yeast Co.), 3.5 % mineral mixture (AIN 93G composition)9) 
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(Oriental Yeast Co.), 1 % vitamin mixture (AIN 93 composition)9) 
(Oriental Yeast Co.), 0.25 % choline bitartrate (Wako Pure Chemical 
Industries, Osaka, Japan), and 0.3 % L-cystine (Wako Pure Chemical 
Industries). After preliminary feeding, the rats were divided into three 
groups (n=7 each) of similar body weights. The first group received a 
subcutaneous implantation of 5×106 RCN-9 cells (provided by the 
RIKEN BRC through the National Bio-Resource Project of the MEXT, 
Japan) suspended in phosphate-buffered saline (PBS(−)) (0.5 ml/rat) in 
the back to produce a solid tumor (tumor-bearing group). The second 
group received a sham injection of PBS(−) alone (0.5 ml/rat) and were 
designated the normal rats (control group). The rats of the third group 
were given the same amount of diet that the tumor-bearing rats ate the 
day before, and this group was designated the pair-fed group. The RCN-
9 cells were prepared by means of a cell culture system. RCN-9 cells 
were cultured in RPMI-1640 medium supplemented with 10 % fetal calf 
serum. The rats of each group were maintained for a further 21 days on 
the basal diet. The diameter of the solid tumor on the backs of the tumor-
bearing rats was measured to estimate the tumor volume every day. 
Water and diet were offered at 7:00 p.m. every day and remained 
available at all times. On the 21st day, all of the rats were deprived of 
their diet at 9:00 a.m. but allowed free access to water until sacrifice, 
which was performed 4 hours later. Blood was collected and left to clot 
at room temperature to obtain serum. The liver, epididymal adipose 
tissue, and solid tumor were quickly removed, washed with cold 0.9 % 
NaCl, blotted on filter paper, and weighed. The serum and liver were 
stored at −30 ℃ until the lipid concentration analyses were performed. 
Aliquots of the liver were also preserved in methanol and stored at 4 ℃ 
until the analyses of the lipid contents were performed. 
Lipid analyses. The lipoprotein separation of serum was as follows, 
HDL was separated from VLDL and LDL by precipitation method 
using sodium phosphotungstic acid and MgCl,10) and VLDL was 
separated from LDL and HDL by ultracentrifugation.11) 
Serum total, HDL-, and (LDL+HDL)-cholesterol, free cholesterol, 
triglyceride, phospholipid, and nonesterified fatty acid (NEFA) 
concentrations were determined by an enzymatic method using a 
Cholesterol E-test, Free cholesterol E-Test, Triglyceride E-test, 
Phospholipid C-test, and NEFA C-test (Wako Pure Chemical Industries), 
respectively. The difference between the total cholesterol concentration 
and HDL-cholesterol concentration was regarded as the (VLDL+LDL)-
cholesterol concentration. The difference between the (LDL+HDL)-
cholesterol concentration and HDL-cholesterol concentration was 
regarded as the LDL-cholesterol concentration. The difference between 
the (VLDL+LDL)-cholesterol concentration and LDL-cholesterol 
concentration was regarded as the VLDL-cholesterol concentration. The 
ratio of the (VLDL+LDL)-cholesterol concentration to HDL-
cholesterol concentration is designated as the atherogenic index. The 
difference between the total cholesterol concentration and free 
cholesterol concentration was regarded as the esterified cholesterol 
concentration, and the ratio of the esterified cholesterol concentration to 
total cholesterol concentration is designated as the cholesterol ratio. 
Total lipids were extracted according to the procedure of Folch et 
al.12) from the liver. After portions of the chloroform phase had been 
dried under nitrogen, the contents of cholesterol,13) triglyceride,14) and 
phospholipid15) were determined. 
The serum and liver thiobarbituric acid-reactive substances 
(TBARS) values were measured according to the method described by 
Yagi16) and Mihara et al.,17) respectively. 
Table 1. Initial body weight, food intake, body weight gain, and weights of liver and epididymal adipose tissue in normal rats fed ad 
libitum (Control), tumor-bearing rats fed ad libitum (Tumor-bearing), and normal rats pair-fed with tumor-bearing rats (Pair-fed). 
Measurement                     Control        Tumor-bearing      Pair-fed 
Initial body weight (g)              81.7 ± 1.1        81.7 ± 1.2        86.0 ± 1.3 
Food intake (g/21d)               242.9 ± 4.3        236.5 ± 6.1       229.9 ± 2.1 
Body weight gain (g/21d)             177.8 ± 3.5         174.4 ± 3.6       171.2 ± 1.6 
Liver weight (g/whole body)            7.48 ± 0.26        6.99 ± 0.25       7.10 ± 0.09 
Epididymal adipose tissue weight (g/whole body)   2.86 ± 0.13        2.66 ± 0.12       2.82 ± 0.18 
Values represent the means ± standard errors for seven rats.  
 
 
 
Fig. 1. Estimated solid tumor volume in tumor-bearing rats. Values 
represent the means for seven rats. Vertical bars indicate standard 
errors. 
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Statistical analysis. Results were expressed as mean ± standard error. 
Statistical analysis was carried out by one-way analysis of variance 
followed by Bonferroni test using the SPSS Statistics, version 21 (IBM 
Japan, Ltd., Tokyo, Japan). Differences were considered significant at p 
< 0.05. 
 
RESULTS 
Table 1 shows the initial body weight, food intake, and body weight 
gain for the 21-day duration of the experimental period, and the weights 
of the liver and epididymal adipose tissue at the end of the experimental 
period. There were no significant differences between the control and 
tumor-bearing groups with regard to the food intake, body weight gain, 
and liver and epididymal adipose tissue weights. In the pair-feeding 
study, the food intake, body weight gain, and weights of the liver and 
epididymal adipose tissue in the pair-fed group were not significantly 
different from those of the control group. The food intake, body weight 
 
Fig. 2. Serum cholesterol concentration, atherogenic index, and cholesterol ratio in normal and tumor-bearing rats. Values represent the means for 
seven rats. Vertical bars indicate standard errors. Values not sharing a common letter are significantly different at p < 0.05 by one-way analysis of 
variance followed by Bonferroni test. C, normal rats fed ad libitum group (control); T, tumor-bearing rats fed ad libitum group; P, normal rats pair-
fed with tumor-bearing rats. 
 
 Fig. 3. Serum triglyceride, phospholipid, and nonesterified fatty acid (NEFA) concentrations in normal and tumor-bearing rats. Values represent the 
means for seven rats. Vertical bars indicate standard errors. C, normal rats fed ad libitum group (control); T, tumor-bearing rats fed ad libitum group; 
P, normal rats pair-fed with tumor-bearing rats. 
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gain, and weights of the liver and epididymal adipose tissue in the pair-
fed group were not significantly different from those of the tumor-
bearing group. 
The absolute and relative weights of the solid tumors at the end of 
the experimental period were 0.33 ± 0.11 g and 0.19 ± 0.06 % of body 
weight, respectively. 
Figure 1 shows the estimated solid tumor volume in the tumor-
bearing rats after RCN-9 implantation. Solid tumors were observed 6−7 
days after RCN-9 implantation, and they continued to grow with time. 
The serum cholesterol concentrations are shown in Figure 2. The 
total cholesterol concentration in the tumor-bearing group was not 
significantly different from that of the control group. Regarding the 
lipoprotein cholesterol, the VLDL-, LDL-, and HDL-cholesterol 
concentrations were not significantly different between the control and 
tumor-bearing groups. The atherogenic index in the tumor-bearing 
group was not significantly different from that of the control group. The 
serum free and esterified cholesterol concentrations were not 
significantly different between the control and tumor-bearing groups. 
The cholesterol ratio in the tumor-bearing group was significantly higher 
than that in the control group. In the pair-feeding study, the total 
cholesterol concentration in the pair-fed group was not significantly 
different from that of the control group. The VLDL-, LDL-, and HDL-
cholesterol concentrations in lipoprotein cholesterol and the free and 
esterified cholesterol concentrations in the pair-fed group were not 
significantly different between the control and pair-fed groups. These 
cholesterol concentrations in the pair-fed group were not significantly 
different compared to those of the tumor-bearing group. The atherogenic 
index and cholesterol ratio in the pair-fed group were not significantly 
different from those of the control group. 
The serum triglyceride, phospholipid, and NEFA concentrations are 
shown in Figure 3. There were no significant differences between the 
control and tumor-bearing groups with regard to the serum triglyceride, 
 
Fig. 4. Liver lipid contents in normal and tumor-bearing rats. Values represent the means for seven rats. Vertical bars indicate standard errors. C, 
normal rats fed ad libitum group (control); T, tumor-bearing rats fed ad libitum group; P, normal rats pair-fed with tumor-bearing rats. 
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Fig. 5. Serum and liver thiobarbituric acid-reactive substances (TBARS) values in normal and tumor-bearing rats. Values represent the means for 
seven rats. Vertical bars indicate standard errors. Values not sharing a common letter are significantly different at p < 0.05 by one-way analysis of 
variance followed by Bonferroni test. C, normal rats fed ad libitum group (control); T, tumor-bearing rats fed ad libitum group; P, normal rats pair-
fed with tumor-bearing rats. 
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phospholipid, and NEFA concentrations. In the pair-feeding study, the 
serum triglyceride, phospholipid, and NEFA concentrations were not 
significantly different between the control and pair-fed groups. These 
serum lipid concentrations in the pair-fed group were not significantly 
different compared to those of the tumor-bearing group. 
   The liver lipid contents are shown in Figure 4. The liver cholesterol, 
triglyceride, and phospholipid contents were not significantly different 
between the control and tumor-bearing groups. In the pair-feeding study, 
there were also no significant differences between the control and pair-
fed groups with regard to the liver cholesterol, triglyceride, and 
phospholipid contents. These liver lipid contents in the pair-fed group 
were not significantly different from those of the tumor-bearing group. 
   The serum and liver TBARS values are shown in Figure 5. Both the 
serum and liver TBARS values in the tumor-bearing group were 
significantly higher than those in the control group. In the pair-feeding 
study, there were no significant differences between the control and pair-
fed groups with regard to the serum and liver TBARS values. The serum 
and liver TBARS values in the pair-fed group were not significantly 
different from those of the tumor-bearing group. 
 
DISCUSSION 
The present study examined the effects of tumor bearing on serum 
lipid concentrations and liver lipid contents in RCN-9-implanted rats. 
The results revealed that RCN-9 implantation to rats significantly 
enhanced their serum and liver TBARS values as compared to the 
control group. TBARS values are an index of lipid peroxidation in the 
blood or tissues. Lipids peroxidize at double bonds between carbon 
atoms of fatty acids. Unsaturated fatty acids have double bonds between 
carbon atoms, and thus these fatty acids are easily oxidized. Srivastava 
et al. reported a significant increase in the plasma levels of TBARS in 
patients with oral cancer compared to control subjects. In cancer patients, 
the unsaturated fatty acids in the cell membranes of the erythrocytes in 
blood are thought to be highly susceptible to oxidative attack. Thus, in 
plasma, the erythrocytes’ cell membrane becomes the major substrate for 
reactive oxygen species-mediated damage.18) This mechanism might 
account for the enhanced serum and liver TBARS values in the present 
study’s RCN-9-implanted rats compared to the control group. 
The study also reported that the levels of superoxide dismutase, 
reduced glutathione, glutathione peroxidase, and catalase, which are 
antioxidant enzymes, were significantly decreased in the oral cancer 
patients compared to healthy subjects, and that the cancer patients also 
showed increased plasma TBARS level.18) It is likely that, in the present 
study’s RCN-9-implanted rats, the antioxidation of unsaturated fatty 
acids in the cell membranes of the erythrocytes and liver might be 
reduced by the suppression of these antioxidant enzyme activities, and 
thus the serum and liver TBARS values were enhanced. A suppression 
of these antioxidant enzyme activities might have been the cause of the 
significant increases in the serum and liver TBARS values of the RCN-
9-implanted rats. 
The effects of diet restriction in tumor-bearing rats was also 
investigated in the present study. Although the RCN-9 implantation 
significantly enhanced the serum and liver TBARS values compared to 
the control group, these TBARS values were not changed by the diet 
restriction. The enhancement of the serum and liver TBARS values 
might be due, at least in part, to the tumor-bearing effect itself and not to 
the suppression of food intake accompanying the tumor-bearing state. 
It is well known that some cancers affect lipid metabolism. For 
example, serum total cholesterol and (VLDL+LDL)-cholesterol 
concentrations were increased in ascites hepatoma cell line AH109A-
bearing rats, whereas the serum HDL-cholesterol concentration 
decreased.5-7) Another study showed that in Lewis lung carcinoma-
implanted mice, the serum total cholesterol and free cholesterol 
concentrations were increased, as was the serum (VLDL+LDL)-
cholesterol concentration.19) In the present study, the RCN-9 
implantation did not change most of the parameters related to lipid 
metabolism. In the tumor-bearing state, the disorder of lipid metabolism 
occurred during the growth of the solid tumor.5) In a previous study of 
tumor-bearing rats, an increase in the plasma triglyceride concentration 
and a suppression of the activities of tissue lipoprotein lipase, the 
hydrolytic enzyme in serum triglyceride, were seen with increased tumor 
burden, and tumor removal completely reversed these changes.20) These 
findings provide evidence that the tumor-induced changes in lipid 
concentrations in blood are stimulated by the presence of the tumor. In 
the present study, the solid tumors were observed within a short time, and 
the growth of the solid tumors was rapid after the RCN-9 implantation 
but slow during the late period. On the 21st day after RCN-9 
implantation, the solid tumor weights were only less than 1 % of the 
body weight. Therefore, most of the parameters related to lipid 
metabolism examined in the present study might not be changed by 
RCN-9 implantation. Tumor cells have a very distinctive metabolism 
with the potential for infinite growth. The reason why the growth of the 
implanted RCN-9 tumor cells was slow is unclear. RCN-9 cells originate 
from F344 rats; rejection of the cells is unlikely in the present 
experimental animals because they too were F344 rats. 
In conclusion, RCN-9 implantation in rats enhanced the serum and 
liver TBARS values. The mechanisms responsible for the observed 
changes in the TBARS values that occurred after RCN-9 implantation 
were not identified, and they remain to be investigated in a future study. 
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和文要旨   大腸癌細胞 RCN-9 移植ラットにおける血清および肝臓脂質レベルに対する担癌の影響を，食餌を自由摂取させた
正常ラット（対照群）およびペアフィーディング正常ラットとの比較で検討した。担癌ラットにはRCN-9 細胞を 5×106移植し 21
日間飼育した。血清および肝臓 TBARS 値が癌の移植後対照群と比較して有意に上昇した。ペアフィーディング群の血清および肝
臓 TBARS 値には対照群と比較して有意な上昇はみられなかった。RNC-9 移植ラットにおいては血清および肝臓 TBARS 値が上昇
し脂質代謝異常が生じたが，これらの上昇には少なくとも一部として担癌そのものの影響が要因となっており，一方，担癌による
飼料摂取量の低下の関与はみられないことが示唆された。 
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